Moderna's mRNA flu shot earns FDA approval after rollercoaster review

Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.

This news item is fetched from a public RSS feed. Title, summary, and image are © their respective publisher; follow the link above to read the full article on the original site.